Stock Track | Celestica Soars 8.35% Pre-Market on Strong Q3 Results and Raised 2025 Outlook

Stock Track
Oct 28, 2025

Shares of Celestica (CLS) surged 8.35% in pre-market trading on Tuesday, following the release of its impressive third-quarter earnings report for 2025. The Toronto-based electronics manufacturing services company not only beat analyst expectations but also raised its fiscal 2025 outlook, triggering a wave of investor enthusiasm.

Celestica reported quarterly earnings of $1.58 per share, significantly surpassing the analyst estimate of $1.47. Revenue for the quarter came in at $3.19 billion, exceeding the Street estimate of $3.01 billion. These results represent substantial year-over-year growth, with earnings per share up 52% and revenue increasing by 28%, both exceeding the high end of the company's guidance ranges.

Adding to the positive sentiment, Celestica raised its fiscal 2025 revenue outlook to $12.2 billion, up from the previous $11.55 billion, and increased its adjusted EPS outlook to $5.90, up from $5.50. CEO Rob Mionis commented on the strong performance, stating, "We achieved very strong results in the third quarter, with revenue of $3.19 billion and non-GAAP adjusted EPS of $1.58, representing growth of 28% and 52%, respectively, each exceeding the high end of our guidance ranges." The company's robust execution was further highlighted by an impressive adjusted operating margin of 7.6%, another high for Celestica.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10